Pulmonary Hypertension Flashcards

1
Q

Technical definition of pulmonary HTN

A

Pulmonary artery pressure >25mmHg at rest or >30mmHg with exercise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cor pulmonale

A

Right ventricular hypertrophy due to disorders of any part of the respiratory apparatus (airways, parenchyma and blood vessels, chest wall, respiratory musculature, or central nervous system controller)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Right ventricular response to acute increase in pulmonary afterload

A

No time to hypertrophy, so the right ventricle is forced to work at higher volumes instead, effectively dilating.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Right ventricular response to chronic increase in pulmonary afterload

A

RVH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pulmonary embolism in pulmonary HTN

A

Pulmonary emboli result in an acute increase in afterload on the RV and resulting pulmonary hypertension when they occlude half to two-thirds of the vessel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Disorders which result in thickening of pulmonary artery walls and subsequent pulmonary HTN due to vessel narrowing

A
  • Idiopathic pulmonary hypertension
  • Hereditary pulmonary arterial hypertension (BMPR2 mutations, result in hyperplasia of pulmonary artery smooth muscle)
  • Scleroderma
  • Certain drugs and toxins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Mechanisms of pulmonary hypertension (6)

A
  1. Occlusion of vessels by emboli
  2. Thickening of arterial walls
  3. Loss of blood vessels due to alveolar scarring or destruction
  4. Pulmonary vasoconstriction (hypoxia or acidosis)
  5. Increased pulmonary flow (left to right shunt, often results in 2 when chronic, leading to Eisenmenger syndrome)
  6. Elevated left atrial and pulmonary venous pressure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Leading factor contributing to pulmonary hypertension in COPD

A

Hypoxic vasoconstriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Histologic changes in pulmonary hypertension

A
  • Intima hyperplasia and media hypertrophy in small vessels
  • Obliteration of the lumen of small vessels (chronic change)
  • Thickening of walls in elastic arteries, resulting in decreased compliance
  • Right ventricular hypertrophy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Plexiform lesions

A

Plexus of small, slit-like vascular channels resulting from proliferation and migration of cells originating in the vessel wall (smooth muscle cells, endothelial cells, and fibroblasts).

Pathognomonic feature of chronic pulmonary arterial hypertension, though pathophysiology is not fully understood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Pulmonary hypertension and thrombosis

A

While pulmonary hypertension may often be caused by thromboembolism, chronic pulmonary hypertension also induces endothelial damage which results in thrombosis within the pulmonary arteries themselves.

This most often occurs in the small arterioles.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

If the primary component of the vascular change occurs at the precapillary level in the pulmonary arteries or arterioles, . . .

A

. . . pulmonary arterial pressures (both systolic and diastolic) rise, but the pressure within pulmonary capillaries remains normal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

If the primary component of the vascular change occurs at the capillary or pulmonary venous level, . . .

A

. . . pulmonary capillary pressure is elevated above its normal level.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Consequences of increased pressure within the pulmonary capillaries

A
  • Fluid hydrostatic leakage into interstitium and alveoli (ie, cardiogenic pulmonary edema)
  • Increased permeability of capillary membranes (ie, non-cardiogenic pulmonary edema)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Why does pulmonary edema occur in right ventricular hypertrophy secondary to left ventricular diastolic failure, but not in primary right ventricular hypertrophy?

A

Because capillary pressures are only increased in left ventricular diastolic failure. In primary right ventricular hypertrophy, pulmonary arterial pressure is likely increased, but capillaries can control their pressure by constricting their arteriolar sphincters and dropping pressure. But if venous pressures are high, capillary pressures must be equally high or higher by necessity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Dyspnea and fatigue in pulmonary hypertension

A

They are observed in pulmonary hypertension even in the absence of any gas exchange problem. This is due to stretch receptors detecting the pressure, not to chemoreceptors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Pulmonary hypertension “chest pressure”

A

Difficult if not impossible to distinguish from angina pectoris.

Also increases with exertion and is usually described as tightness. Presumed to be related to ischemia of the right ventricle due to the large metabolic demand of pumping frequently against a high afterload.

Strong exertion may result in transient right ventricle failure, lightheadedness, and syncopy. This is a very poor prognostic sign.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Cardiac exam in isolated pulmonary hypertension

A
  • Accentuated P2
  • Tricuspid regurgitation murmur
  • Graham Steell murmur (murmur of pulmonary HTN)
  • Pulmonary artery tap
  • LLSB heave
  • R sided S4 gallop (indicates RVH)
  • R sided S3 gallop (indicates RV failure)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Pulmonary artery tap

A

When the pulmonary artery is enlarged, a pulsation may be felt at the left upper sternal border

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Diagnosis of pulmonary hypertension

A

Requires cardiac catheterization and accurate hemodynamic measurements of pulmonary arterial and pulmonary venous pressures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is going on in this radiograph?

A

Pulmonary arterial hypertension. The lesions are enlarged central pulmonary arteries. Notice that the smaller vessels taper off quickly after stemming off from them.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

When there is elevation of pulmonary venous pressure from mitral stenosis or left ventricular failure, the chest radiograph often shows . . .

A

. . . redistribution of blood flow from lower to upper lung zones, accompanied by evidence of interstitial or alveolar edema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Group 1 pulmonary arterial hypertension

A
  • Associated with isolated elevations in pulmonary vascular resistance.
  • idiopathic PAH
  • scleroderma
  • portal HTN and cirrhosis
  • HIV
  • drug and toxin-induced PAH (especially appetite suppressants)
24
Q

Some clinical features of idopathic PAH

A
  • 80% women
  • Associated with Raynaud’s phenomenon
  • Clinically indistinguishable from familial PAH
  • Poor prognosis - often death within years of diagnosis
25
Q

Treatment of PAH

A
  • Vasodilators and anti-remodeling agents
    • Prior to treatment, acute vasodilator testing with NO is used to assess responsiveness
    • Dihydropyridine CCBs in those who normalize pressure on test
    • For the others: Endothelin-1 receptor antagonists, prostacyclin derivatives, and phosphodiesterase inhibitors
  • Long term anti-coagulation with warfarin
26
Q

Group 2 pulmonary HTN (Due to heart disease)

A
  • Mostly mitral stenosis and LV diastolic failure
  • Elevated venous pressures as well
  • Extravasated erythrocytes, which are taken up by alveolar macrophages and result in hemosiderin buildup
  • Some fibrosis in chronic HTN
  • Treatment is primarily focused on the primary cardiac disease
27
Q

Radiographic findings in venous HTN

A
  • Cephalization
  • Interstitial and alveolar edema
  • Kerley B lines
28
Q

Group 3 pulmonary HTN owing to lung disease and/or hypoxia

A
  • Aka cor pulmonale
  • Most commonly caused by COPD and interstitial lung disease
  • Hypoxic and acidotic vasoconstriction major drivers
  • Polycythemia due to chronic hypoxemia also a culprit (increased blood viscosity)
29
Q

Group 4 pulmonary HTN owing to chronic pulmonary embolism

A
  • Often insidious onset with dyspnea without prior history of pulmonary embolism
  • Many small emboli rather than one large one
  • Chronic, so most are infiltrated by fibroblasts and organized
  • Anticoagulation alone is insufficient
  • If in large arteries, may be surgically removed
  • Microvascular form involves anticoagulation and chronic vasodilation
30
Q

Group 5 pulmonary HTN with unclear multifactorial mechanisms

A
  • Umbrella category of many diseases which case secondary pulmonary HTN
  • Major component is sarcoidosis
31
Q

Cappilary surface area in the lungs that praticipates in gas exchange

A

About 125 m2

32
Q

Right vs left lung systemic vascular supply

A

The right lung has one bronchial artery of variable origin

The left lung has two bronchial arteries which almost always stem off of the aorta

Thus, the right lung is more prone to occlusion via the bronchial artery.

33
Q

Systolic and diastolic pressures in the pulmonary artery

A

25 mmHg / 10 mmHg

34
Q

Calculating pulmonary vascular resistance

A

Find mean pressure in pulmonary artery (mPA) and left atrium (mLA) by cardiac catheterization.

Then enter into the equation:

PVR = (mPA - mLA) / CO

35
Q

Wood units

A

Standard unit of measure for vascular resistance

1 Wood unit = 1 mmHg/L/min

Where L/min is the unit of cardiac output Q

36
Q

Under normal resting conditions, some pulmonary vessels receive . . .

A

. . . no blood flow, but are capable of carrying part of the pulmonary blood flow should the pressure increase.

This is a key mechanism, as it allows PVR to decrease as CO and pressure increases

37
Q

Major factors that affect pulmonary vessel volume

A
  • Pulmonary artery compliance
  • How many pulmonary vessels are currently filled
  • Lung volume
38
Q

Alveolar vessels

A

Include the capillary network in alveolar walls, which are compressed upon inspiration due to the increased pressure within the alveoli, transiently raising their resistance.

39
Q

Extraalveolar vessels

A

Vessels that are not compressed by air-filled alveoli. Tethered to the lung walls in such a way that allows them to expand as the lung expands, counteracting the increased resistance in alveolar vessels during inspiration.

40
Q

The total PVR is smallest during ___, when the lung is ___.

A

The total PVR is smallest during resting end-expiration, when the lung is at FRC.

41
Q

Total, alveolar, and extraalveolar PVR plot

A
42
Q

Because the top of the lung is approximately 15 cm above the level of the main pulmonary arteries, a pressure of ___ is required to achieve perfusion of the apices.

A

Because the top of the lung is approximately 15 cm above the level of the main pulmonary arteries, a pressure of 15 cm H2O is required to achieve perfusion of the apices.

43
Q

Perfusion scan

A

The distribution of blood flow in the lung can be measured with radioactive isotopes.

Intravenous injection of radiolabeled particles, specifically macroaggregates of albumin, are of sufficient size to lodge in the pulmonary capillaries.

44
Q

The lung as an endocrine organ

A

The pulmonary circulation has an important role in the inactivation of certain circulating bioactive chemicals.

For example, serotonin and bradykinin are primarily inactivated in the lung, probably at the level of the vascular endothelium.

In addition, angiotensin I is converted to angiotensin II by angiotensin-converting enzyme, which is produced by pulmonary vascular endothelial cells. This same enzyme, ACE-2, is the entry receptor for SARS-CoV-2.

45
Q

New definition of pulmonary HTN

A
  • Mean PA pressure > 20 mmHg
  • AND >3 Woods Units of PVR to be considered “pre-capillary”
46
Q

Exercise-induced asthma . . .

A

. . . respond to treatment.

VERY frequently, people with pulmonary arterial hypertension are erroneously diagnosed and treated with exercise-induced asthma. If someone doesn’t improve on therapy for exercise-induced asthma, they probably have pulmonary arterial hypertension.

47
Q

PHTN profiles (numerically in terms of PVR, PAP, PVP)

A
48
Q

Patients with longstanding diastolic dysfunction (over years), treating for pulmonary arterial hypertension with vasodilators that act on the pulmonary arteries, why do they tend to be worse off on this treatment regimen?

A

The vasodilator decreases PVR, but the LA pressure has not changed. This means that all you have done is flood the system with fluid. This will result in pulmonary edema.

49
Q

Why is shortness of breath worse in PAH?

A

Normally, passive distension and vasodilation allows PVR to decrease as CO increases, maintaining a steady pressure.

However, in individuals with PAH, the PVR is high and fixed, and an increase in right heart cardiac output results in an increased pressure. Dyspnea is likely due to increased stretch in the walls of the PA due to the increased pressure, but may also be due to transient increase in pulmonary edema.

Against an especially high afterload, the RV stroke volume drops precipitously.

50
Q

Normal pulmonary arteriole and PAH arteriole H and E

A

PAH is on the right. This helps you picture why a vasodilator is going to do absolutely nothing to help.

51
Q

What is shown in this pulmonary arteriole?

A

A plexiform lesion, pathognomonic of PAH.

52
Q

DLCO in PAH

A

Often decreased due to loss of vessels. This is sometimes the only PFT that is off in these patients, and can be an important diagnostic clue.

53
Q

BMPRII signaling

A

Antagonizes TGFb, opposing vasculature changes. Heritable defects associated with familial pulmonary hypertension.

54
Q

Current therapies for PAH

A
55
Q

Treprostanil

A

Common treatment for PAH. Continuous intravenous catheter, which is portable and maintained by the patient. Treprostanil is a prosyacyclin analog.

56
Q

Targeting cGMP in PAH

A

The two drugs in the upper right are viagra and cialis.

NOTE that nitrates and viagra/cialis together result in dangerously high levels of cGMP, leading to pulmonary and systemic hypotension. This is a classic contraindication that will be on the Boards.